Related Experiment Video
Updated: Jul 17, 2026
10:34
Identification of Sleeping Beauty Transposon Insertions in Solid Tumors using Linker-mediated PCR
Published on: February 1, 2013
Transgenic tumor models for carcinogen identification: the heterozygous Trp53-deficient and RasH2 mouse lines
R D Storer1, J E French, L A Donehower
1Department of Genetic and Cellular Toxicology, Merck Research Laboratories, WP45-311, West Point, PA 19486, USA. richard_storer@merck.com
Mutation Research
|October 11, 2003
Summary
Genetically altered mouse models (GAMM) show promise for identifying human carcinogens in short-term studies. Further research will optimize protocols and enhance understanding of chemical interactions for public health benefits.
Area of Science:
- Oncology
- Toxicology
- Genetics
Background:
- Genetically altered mouse models (GAMM) are crucial for studying human cancer genetics and phenotypes.
- These models aid in identifying potential human carcinogens and understanding carcinogen-gene interactions.
- Specific models like B6.129N5-Trp53 and CB6F1-RasH2 mice are extensively studied.
Purpose of the Study:
- To develop recommendations for genetic/molecular characterization in GAMM for carcinogen identification.
- To identify knowledge gaps in the current understanding of GAMM in carcinogenicity testing.
- To propose research strategies for advancing the use of GAMM in toxicological studies.
Main Methods:
- Utilizing 26-week exposure protocols at or near maximum tolerated dose in GAMM.
- Focusing on genetic and molecular characterization of animals, tissues, and tumors before and after chemical exposure.
- Investigating short-term, mechanism-based carcinogenicity experiments.
Main Results:
- GAMM demonstrate potential for identifying and classifying chemical risks to humans through short-term carcinogenicity experiments.
- The study session aimed to establish standardized characterization protocols for GAMM.
- Preliminary results suggest the utility of GAMM in predicting human carcinogens.
Conclusions:
- Optimization of protocols and identification of significant responses in GAMM can aid in developing prevention and intervention strategies.
- Further research is needed to fill knowledge gaps and refine the application of GAMM in toxicology.
- GAMM hold significant potential for improving public health through enhanced carcinogen risk assessment.
Related Concept Videos
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
02:43Mouse Models of Cancer Study
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:25Mutagenicity and Carcinogenicity
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...